Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $19,121 - $49,928
-35,410 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$1.4 - $5.15 $140 - $515
100 Added 0.28%
35,410 $51,000
Q3 2021

Nov 10, 2021

SELL
$5.31 - $8.25 $13,274 - $20,625
-2,500 Reduced 6.61%
35,310 $206,000
Q2 2021

Jul 30, 2021

BUY
$6.81 - $9.23 $22,473 - $30,459
3,300 Added 9.56%
37,810 $305,000
Q1 2021

May 06, 2021

SELL
$7.99 - $15.0 $103,870 - $195,000
-13,000 Reduced 27.36%
34,510 $287,000
Q4 2020

Feb 08, 2021

BUY
$7.04 - $11.7 $18,304 - $30,419
2,600 Added 5.79%
47,510 $360,000
Q3 2020

Nov 12, 2020

SELL
$9.98 - $18.04 $82,834 - $149,732
-8,300 Reduced 15.6%
44,910 $479,000
Q2 2020

Aug 13, 2020

BUY
$7.49 - $15.16 $46,438 - $93,992
6,200 Added 13.19%
53,210 $807,000
Q1 2020

May 14, 2020

BUY
$4.62 - $18.74 $40,656 - $164,912
8,800 Added 23.03%
47,010 $392,000
Q4 2019

Feb 18, 2020

SELL
$14.6 - $18.13 $29,200 - $36,260
-2,000 Reduced 4.97%
38,210 $646,000
Q2 2019

Aug 14, 2019

BUY
$17.79 - $22.88 $60,486 - $77,792
3,400 Added 9.24%
40,210 $920,000
Q1 2019

May 14, 2019

SELL
$11.76 - $22.15 $35,691 - $67,225
-3,035 Reduced 7.62%
36,810 $774,000
Q4 2018

Feb 13, 2019

BUY
$10.42 - $21.94 $1,406 - $2,961
135 Added 0.34%
39,845 $458,000
Q2 2018

Aug 13, 2018

BUY
$19.02 - $24.95 $72,276 - $94,810
3,800 Added 10.58%
39,710 $886,000
Q1 2018

May 14, 2018

BUY
$22.55 - $29.9 $74,415 - $98,670
3,300 Added 10.12%
35,910 $821,000
Q4 2017

Feb 13, 2018

SELL
$18.0 - $30.0 $43,200 - $72,000
-2,400 Reduced 6.86%
32,610 $854,000
Q3 2017

Nov 13, 2017

BUY
$21.1 - $25.15 $738,711 - $880,501
35,010
35,010 $786,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.